Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Robust Intratumor Partitioning To Identify High-Risk Subregions In Lung Cancer: A Pilot Study.

J. Wu, M. Gensheimer, Xinzhe Dong, D. Rubin, S. Napel, M. Diehn, B. Loo, R. Li
Published 2016 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
PURPOSE To develop an intratumor partitioning framework for identifying high-risk subregions from (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) and computed tomography (CT) imaging and to test whether tumor burden associated with the high-risk subregions is prognostic of outcomes in lung cancer. METHODS AND MATERIALS In this institutional review board-approved retrospective study, we analyzed the pretreatment FDG-PET and CT scans of 44 lung cancer patients treated with radiation therapy. A novel, intratumor partitioning method was developed, based on a 2-stage clustering process: first at the patient level, each tumor was over-segmented into many superpixels by k-means clustering of integrated PET and CT images; next, tumor subregions were identified by merging previously defined superpixels via population-level hierarchical clustering. The volume associated with each of the subregions was evaluated using Kaplan-Meier analysis regarding its prognostic capability in predicting overall survival (OS) and out-of-field progression (OFP). RESULTS Three spatially distinct subregions were identified within each tumor that were highly robust to uncertainty in PET/CT co-registration. Among these, the volume of the most metabolically active and metabolically heterogeneous solid component of the tumor was predictive of OS and OFP on the entire cohort, with a concordance index or CI of 0.66-0.67. When restricting the analysis to patients with stage III disease (n=32), the same subregion achieved an even higher CI of 0.75 (hazard ratio 3.93, log-rank P=.002) for predicting OS, and a CI of 0.76 (hazard ratio 4.84, log-rank P=.002) for predicting OFP. In comparison, conventional imaging markers, including tumor volume, maximum standardized uptake value, and metabolic tumor volume using threshold of 50% standardized uptake value maximum, were not predictive of OS or OFP, with CI mostly below 0.60 (log-rank P>.05). CONCLUSION We propose a robust intratumor partitioning method to identify clinically relevant, high-risk subregions in lung cancer. We envision that this approach will be applicable to identifying useful imaging biomarkers in many cancer types.
This paper references
10.1016/j.ijrobp.2014.10.012
Evaluating tumor response of non-small cell lung cancer patients with ¹⁸F-fludeoxyglucose positron emission tomography: potential for treatment individualization.
I. Toma-Dasu (2015)
10.1111/1467-9868.00293
Estimating the number of clusters in a dataset via the gap statistic
R. Tibshirani (2000)
10.1016/j.ijrobp.2014.07.020
Prognostic value and reproducibility of pretreatment CT texture features in stage III non-small cell lung cancer.
D. Fried (2014)
Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography.
H. Vesselle (2000)
10.1007/s00259-011-1934-6
Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer
S. Liao (2011)
10.1016/j.ijrobp.2012.10.036
Physiological imaging-defined, response-driven subvolumes of a tumor.
R. Farjam (2013)
10.1016/j.ijrobp.2009.08.018
Accurate automatic delineation of heterogeneous functional volumes in positron emission tomography for oncology applications.
M. Hatt (2010)
A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities
Z. Zhou (2015)
10.1016/j.acra.2012.07.002
Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
H. Zhang (2013)
10.1148/radiol.13122697
Quantitative imaging in cancer evolution and ecology.
R. Gatenby (2013)
10.1371/journal.pone.0118261
Quantitative Computed Tomographic Descriptors Associate Tumor Shape Complexity and Intratumor Heterogeneity with Prognosis in Lung Adenocarcinoma
O. Grove (2015)
10.1007/BF02289588
Hierarchical clustering schemes
S. C. Johnson (1967)
10.1093/BIOSTATISTICS/KXJ029
Are clusters found in one dataset present in another dataset?
A. Kapp (2007)
10.1148/radiol.2016151829
Early-Stage Non-Small Cell Lung Cancer: Quantitative Imaging Characteristics of (18)F Fluorodeoxyglucose PET/CT Allow Prediction of Distant Metastasis.
J. Wu (2016)
10.1148/radiol.2015142920
Stage III Non-Small Cell Lung Cancer: Prognostic Value of FDG PET Quantitative Imaging Features Combined with Clinical Prognostic Factors.
D. Fried (2016)
10.1186/1748-717X-9-50
Deformable versus rigid registration of PET/CT images for radiation treatment planning of head and neck and lung cancer patients: a retrospective dosimetric comparison
D. Fortin (2014)
10.1093/jnci/djv004
Pretreatment FDG-PET metrics in stage III non-small cell lung cancer: ACRIN 6668/RTOG 0235.
N. Ohri (2015)
10.1016/S0360-3016(03)00346-8
Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study.
I. Ciernik (2003)
10.1148/radiol.2015150358
Prognostic Imaging Biomarkers in Glioblastoma: Development and Independent Validation on the Basis of Multiregion and Quantitative Analysis of MR Images.
Y. Cui (2016)
10.1016/j.ijrobp.2013.10.029
Pretreatment [18F]-fluoro-2-deoxy-glucose positron emission tomography maximum standardized uptake value as predictor of distant metastasis in early-stage non-small cell lung cancer treated with definitive radiation therapy: rethinking the role of positron emission tomography in personalizing treatm
V. Nair (2014)
10.1016/j.ijrobp.2013.09.037
Modeling pathologic response of esophageal cancer to chemoradiation therapy using spatial-temporal 18F-FDG PET features, clinical parameters, and demographics.
H. Zhang (2014)
10.1109/TMI.2009.2035616
elastix: A Toolbox for Intensity-Based Medical Image Registration
S. Klein (2010)
10.1056/NEJMoa0900043
Preoperative staging of lung cancer with combined PET-CT.
B. Fischer (2009)
10.1158/1078-0432.CCR-14-0990
Imaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome
J. O'Connor (2014)
10.1016/j.radonc.2015.02.015
CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma.
T. Coroller (2015)
10.1109/TPAMI.2002.1017616
An Efficient k-Means Clustering Algorithm: Analysis and Implementation
T. Kanungo (2002)
Non-small Cell Lung Cancer Treatment
C. Manegold (2007)
10.1016/j.cllc.2011.05.001
Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-small-cell lung cancer.
P. Lee (2012)
10.1016/S1470-2045(14)71207-0
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
J. Bradley (2015)
10.1158/1078-0432.CCR-14-1524
In Vivo Quantification of Hypoxic and Metabolic Status of NSCLC Tumors Using [18F]HX4 and [18F]FDG-PET/CT Imaging
C. M. Zegers (2014)
10.2967/jnumed.111.102566
Response Assessment Using 18F-FDG PET Early in the Course of Radiotherapy Correlates with Survival in Advanced-Stage Non–Small Cell Lung Cancer
W. V. van Elmpt (2012)
10.2967/jnumed.114.144055
18F-FDG PET Uptake Characterization Through Texture Analysis: Investigating the Complementary Nature of Heterogeneity and Functional Tumor Volume in a Multi–Cancer Site Patient Cohort
M. Hatt (2015)
10.1148/radiol.13130652
Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value.
Y. Satoh (2014)
10.2967/jnumed.112.107375
Are Pretreatment 18F-FDG PET Tumor Textural Features in Non–Small Cell Lung Cancer Associated with Response and Survival After Chemoradiotherapy?
G. Cook (2013)
10.1002/jmri.25279
Intratumor partitioning and texture analysis of dynamic contrast‐enhanced (DCE)‐MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy
J. Wu (2016)
10.1038/ncomms5006
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
H. Aerts (2014)
10.2967/jnumed.111.096305
Large Decreases in Standardized Uptake Values After Definitive Radiation Are Associated with Better Survival of Patients with Locally Advanced Non–Small Cell Lung Cancer
J. L. Lopez Guerra (2012)
10.1118/1.1809778
Four-dimensional (4D) PET/CT imaging of the thorax.
S. Nehmeh (2004)
10.1118/1.4737022
An approach to identify, from DCE MRI, significant subvolumes of tumors related to outcomes in advanced head-and-neck cancer.
Peng Wang (2012)
10.1158/1078-0432.CCR-12-1307
Tumor Heterogeneity and Permeability as Measured on the CT Component of PET/CT Predict Survival in Patients with Non–Small Cell Lung Cancer
T. Win (2013)
10.1016/j.patcog.2008.08.011
Exploring feature-based approaches in PET images for predicting cancer treatment outcomes
I. El-Naqa (2009)
10.1200/JCO.2012.47.5947
Prediction of survival by [18F]fluorodeoxyglucose positron emission tomography in patients with locally advanced non-small-cell lung cancer undergoing definitive chemoradiation therapy: results of the ACRIN 6668/RTOG 0235 trial.
M. Machtay (2013)



This paper is referenced by
10.3390/cancers12103047
Comprehensive Analysis of Tumour Sub-Volumes for Radiomic Risk Modelling in Locally Advanced HNSCC
S. Leger (2020)
10.1002/jmri.25279
Intratumor partitioning and texture analysis of dynamic contrast‐enhanced (DCE)‐MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy
J. Wu (2016)
Advanced Imaging Analysis for Predicting Tumor Response and Improving Contour Delineation Uncertainty
Rebecca Nichole Mahon (2018)
10.1007/s00330-018-5590-0
Clustering approach to identify intratumour heterogeneity combining FDG PET and diffusion-weighted MRI in lung adenocarcinoma
JongHoon Kim (2018)
10.1007/s13139-017-0506-5
CT Radiomics in Thoracic Oncology: Technique and Clinical Applications
G. Lee (2017)
10.1016/j.radonc.2017.09.041
Clustering of multi-parametric functional imaging to identify high-risk subvolumes in non-small cell lung cancer.
Aniek J. G. Even (2017)
10.1109/BIBM47256.2019.8983174
Pixel-Level Clustering Reveals Intra-Tumor Heterogeneity in Non-Small Cell Lung Cancer
J. Li (2019)
10.1016/j.ejrad.2016.09.005
Radiomics and its emerging role in lung cancer research, imaging biomarkers and clinical management: State of the art.
G. Lee (2017)
10.1016/j.ijrobp.2018.01.006
A Quantitative CT Imaging Signature Predicts Survival and Complements Established Prognosticators in Stage I Non-Small Cell Lung Cancer.
Juheon Lee (2018)
10.1038/srep38282
Non-small cell lung cancer: quantitative phenotypic analysis of CT images as a potential marker of prognosis
J. Song (2016)
10.1088/0031-9155/61/24/8440
Automatic metastatic brain tumor segmentation for stereotactic radiosurgery applications.
Y. Liu (2016)
10.1007/s11307-020-01507-7
Extracting and Selecting Robust Radiomic Features from PET/MR Images in Nasopharyngeal Carcinoma
P. Yang (2020)
10.7150/thno.50565
Early response evaluation using primary tumor and nodal imaging features to predict progression-free survival of locally advanced non-small cell lung cancer
N. Zhang (2020)
10.1088/1361-6560/aaa609
Radiogenomics of hepatocellular carcinoma: multiregion analysis-based identification of prognostic imaging biomarkers by integrating gene data-a preliminary study.
W. Xia (2018)
10.1007/978-3-319-66185-8_53
RADIomic Spatial TexturAl descripTor (RADISTAT): Characterizing Intra-tumoral Heterogeneity for Response and Outcome Prediction
Jacob Antunes (2017)
10.1016/j.semcancer.2020.12.005
Integrated imaging and molecular analysis to decipher tumor microenvironment in the era of immunotherapy.
J. Wu (2020)
10.1088/1361-6560/ab6e51
A prognostic analysis method for non-small cell lung cancer based on the computed tomography radiomics.
X. Wang (2020)
10.1016/j.radonc.2020.07.030
Prognostic factors for overall survival of stage III non-small cell lung cancer patients on computed tomography: a systematic review and meta-analysis.
Myra van Laar (2020)
10.1109/IST.2018.8577128
DCE-MRI radiomics features for predicting breast cancer neoadjuvant therapy response
E. Kontopodis (2018)
10.1093/jrr/rrx102
Radiomics and radiogenomics for precision radiotherapy
J. Wu (2018)
10.1016/j.ebiom.2019.05.023
Sub-region based radiomics analysis for survival prediction in oesophageal tumours treated by definitive concurrent chemoradiotherapy
C. Xie (2019)
10.1016/j.ejmp.2019.03.024
Early survival prediction in non-small cell lung cancer from PET/CT images using an intra-tumor partitioning method.
M. Astaraki (2019)
10.1259/bjr.20170267
Clinical applications of textural analysis in non-small cell lung cancer.
I. Phillips (2018)
10.1016/j.radphyschem.2020.108763
Dosimetric assessment in different tumour phenotypes with auger electron emitting radionuclides: 99mTc, 125I, 161Tb, and 177Lu
Jorge Borbinha (2020)
10.14569/IJACSA.2017.080901
The Analysis of Anticancer Drug Sensitivity of Lung Cancer Cell Lines by using Machine Learning Clustering Techniques
Chandi S. Wanigasooriya (2017)
10.1088/1361-6560/aad648
Intra-tumoural heterogeneity characterization through texture and colour analysis for differentiation of non-small cell lung carcinoma subtypes.
Yuan Ma (2018)
10.1007/s00234-020-02529-2
Diffusion tensor and postcontrast T1-weighted imaging radiomics to differentiate the epidermal growth factor receptor mutation status of brain metastases from non-small cell lung cancer
Y. Park (2020)
10.1002/jso.25901
Performance evaluation of texture analysis based on kinetic parametric maps from breast DCE‐MRI in classifying benign from malignant lesions
Zejun Jiang (2020)
10.1007/s11307-019-01439-x
Subregional Radiomics Analysis of PET/CT Imaging with Intratumor Partitioning: Application to Prognosis for Nasopharyngeal Carcinoma
Hui Xu (2019)
10.1016/J.ORALONCOLOGY.2019.04.021
Feasibility of multiparametric imaging with PET/MR in nasopharyngeal carcinoma: A pilot study.
C. Cao (2019)
A Bayesian Nonparametric model for textural pattern heterogeneity
Xiaoqin Li (2020)
10.1016/j.radonc.2017.08.007
Mid-radiotherapy PET/CT for prognostication and detection of early progression in patients with stage III non-small cell lung cancer.
M. Gensheimer (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar